253 related articles for article (PubMed ID: 31401901)
1. Synthesis and enzyme-based evaluation of analogues
Khalili Arjomandi O; Kavoosi M; Adibi H
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1414-1425. PubMed ID: 31401901
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.
Arjomandi OK; Hussein WM; Vella P; Yusof Y; Sidjabat HE; Schenk G; McGeary RP
Eur J Med Chem; 2016 May; 114():318-27. PubMed ID: 27017264
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.
Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI
ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956
[TBL] [Abstract][Full Text] [Related]
4. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors.
Yan YH; Li W; Chen W; Li C; Zhu KR; Deng J; Dai QQ; Yang LL; Wang Z; Li GB
Eur J Med Chem; 2022 Jan; 228():113965. PubMed ID: 34763944
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and investigation of inhibitory activities of imidazole derivatives against the metallo-β-lactamase IMP-1.
Khalili Arjomandi O; Kavoosi M; Adibi H
Bioorg Chem; 2019 Nov; 92():103277. PubMed ID: 31539743
[TBL] [Abstract][Full Text] [Related]
7. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.
Skagseth S; Akhter S; Paulsen MH; Muhammad Z; Lauksund S; Samuelsen Ø; Leiros HS; Bayer A
Eur J Med Chem; 2017 Jul; 135():159-173. PubMed ID: 28445786
[TBL] [Abstract][Full Text] [Related]
8. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.
Liu B; Trout REL; Chu GH; McGarry D; Jackson RW; Hamrick JC; Daigle DM; Cusick SM; Pozzi C; De Luca F; Benvenuti M; Mangani S; Docquier JD; Weiss WJ; Pevear DC; Xerri L; Burns CJ
J Med Chem; 2020 Mar; 63(6):2789-2801. PubMed ID: 31765155
[TBL] [Abstract][Full Text] [Related]
10. H
Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
[TBL] [Abstract][Full Text] [Related]
11. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
[TBL] [Abstract][Full Text] [Related]
12. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
[TBL] [Abstract][Full Text] [Related]
13. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
[TBL] [Abstract][Full Text] [Related]
15. Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors.
Rotter MJ; Zentgraf S; Weizel L; Frank D; Burgers LD; Brunst S; Fürst R; Proschak A; Wichelhaus TA; Proschak E
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838971
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.
Meletiadis J; Paranos P; Georgiou PC; Vourli S; Antonopoulou S; Michelaki A; Vagiakou E; Pournaras S
Int J Antimicrob Agents; 2021 Nov; 58(5):106440. PubMed ID: 34551356
[TBL] [Abstract][Full Text] [Related]
17. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S
J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013
[TBL] [Abstract][Full Text] [Related]
18. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
Nagulapalli Venkata KC; Ellebrecht M; Tripathi SK
Eur J Med Chem; 2021 Dec; 225():113747. PubMed ID: 34391033
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of (2-mercaptoacetyl)-L-[2-
Shirvani G; Shockravi A; Amini M; Saemian N
J Labelled Comp Radiopharm; 2017 Feb; 60(2):130-134. PubMed ID: 27943428
[TBL] [Abstract][Full Text] [Related]
20. Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.
Davies DT; Everett M
Acc Chem Res; 2021 May; 54(9):2055-2064. PubMed ID: 33788541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
